Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power.

Research Grants 373 show all


$33.6M
2016

$158M
2017

$185.7M
2018

$131M
2019

$7.5M
2020

Patents 270,037show all

  • 40,906
    C07D - Heterocyclic compounds
  • 27,353
    A01N - Preservation of bodies of humans or animals or plants or parts thereof
  • 25,067
    C08G - Macromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds
  • 23,848
    C07C - Acyclic or carbocyclic compounds
  • 12,829
    A61K - Preparations for medical, dental, or toilet purposes
  • 10,342
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 9,232
    C09B - Organic dyes or closely-related compounds for producing dyes
  • 8,973
    C08L - Compositions of macromolecular compounds
  • 8,480
    C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients
  • 6,671
    C08F - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

Clinical Trials 3,662show all

893Phase 3824N/A736Phase 2357Phase 1242Phase 4113Other

Contact Information

Leverkusen
Germany

Overview

Total FundingEmployeesLast Funding DateStatus
unknownOperating